您的位置：首页 > 产品展示 > 原料药| 原料药 | API | 状态 | 规格 | 文件 |
| 瑞舒∑ 伐他汀钙 | Rosuvastatin Ca | 商业化 | EP | EDMF, USDMF, CEP 2018 |
| 阿托伐他汀钙三←水合物 | Atorvastatin Ca | 商业化 | EP, USP | EDMF, USDMF |
| 依替米贝 | Ezetimibe | 商业化 | In house (ICH) | EDMF plan |
| 缬沙坦 | Valsartan | 商业化 | EP, USP | EDMF, USDMF |
| 氯沙坦钾 | Losartan Potassium | 商业化 | EP, USP | EDMF, CEP |
| 坎地╱沙坦酯 | Candesartan Cilexetil | 商业化 | EP, USP | EDMF |
| 奥美沙坦酯 | Olmesartan Medoxomil | 商业化 | EP, USP | EDMF |
| 培哚普利叔丁胺盐 | Perindopril Erbumine | 商业化 | EP | EDMF |
| 培哚普利精氨酸盐 | Perindopril Arginine | 待验证 | In house (ICH) | EDMF plan |
| 盐酸伊伐布雷①定 | Ivabradine HCl | 商业化 | In house (ICH) | EDMF |
| 埃索美拉唑镁二水合物 | Esomeprazole Mg Dihydrate | 商业化 | EP | EDMF, USDMF, CEP 2017 |
| 埃索美↓拉唑镁三水合物 | Esomeprazole Mg Trihydrate | 商业化 | EP, USP | EDMF, CEP 2018 |
| 埃索美拉唑钠 | Esomeprazole Na | 待验证 | In house (ICH) | EDMF plan |
| 氯吡格雷硫酸氢盐 | Clopidogrel Bisulfate | 商业化 | EP, USP | EDMF |
| 达比加群◇酯甲磺酸盐 | Dabigatran Etexilate Mesylate | 待验证 | In house (ICH) | EDMF plan |
| 替格瑞洛 | Ticagrelor | 待验证 | In house (ICH) | EDMF plan |
| 利伐沙班 | Rivaroxaban | 待验证 | In house (ICH) | EDMF plan |
| 阿哌沙班 | Apixaban | 研发 | In house (ICH) | EDMF to be prepared |
| 盐酸文⌒拉法辛 | Venlafaxine HCl | 商业化 | EP, USP | EDMF, CEP |
| 盐酸度洛西汀 | Duloxetine HCl | 商业化 | EP, USP | EDMF, CEP |
| 加★兰他敏氢溴酸盐 | Galantamine HBr | 商业化 | EP, USP | EDMF plan |
| 普瑞巴林 | Pregabalin | 商业化 | In house (ICH) | EDMF plan |
| 沙芬酰胺 | Safinamide | 待验证 | In house (ICH) | EDMF plan |
| 维达列汀 | Vildagliptin | 商业化 | In house (ICH) | EDMF |
| 阿格列汀苯甲∞酸盐 | Alogliptin Benzoate | 待验证 | In house (ICH) | EDMF plan |
| 西他列♀汀磷酸盐 | Sitagliptin Phosphate | 待验证 | In house (ICH) | EDMF plan |
| 达格列净 | Dapagliflozin | 待验证 | In house (ICH) | EDMF plan |
| 替诺福韦酯富马酸↙盐 | Tenofovir Disoproxil Fumarate | 待验证 | In house (ICH) | EDMF plan |
| 替诺福韦艾拉酚胺 | Tenofovir Alafenamide | 研发 | In house (ICH) | EDMF to be prepared |
| 维帕他韦 | Velpatasvir | 研发 | In house (ICH) | EDMF to be prepared |
| 索菲布韦 | Sofosbuvir | 研发 | In house (ICH) | EDMF to be prepared |
| 盐酸厄洛替¤尼 | Erlotinib HCl | 待验证 | In house (ICH) | EDMF plan |
| 索拉菲尼 | Sorafinib | 研发 | In house (ICH) | EDMF to be prepared |
| 盐酸莫西沙星 | Moxifloxacin HCl | 商业化 | EP, USP | EDMF |
| 雷西纳德 | Lesinurad | 待验证 | In house (ICH) | EDMF plan |
| 氟虫腈 | Fipronil | 商业化 | In house (ICH) | EDMF |
| 氟苯尼考 | Florfenicol | 商业化 | In house (ICH) | EDMF |
| 马波沙星 | Marbofloxacin | 商业化 | EP | EDMF |
| 普多沙星 | Pradofloxacin | 研发 | In house (ICH) | EDMF to be prepared |
| 微丸 | Pellets | 规格 | ||
| 埃索∞美拉唑镁微丸 | Esomeprazole Mg Pellets | 商业化 | 22.5%, 8.5% | |
| 奥利ω 司他微丸 | Orlistat Pellets | 商业化 | 50% | |
| 盐酸文拉法辛微◆丸 | Venlafaxine HCl Pellets | 商业化 | 46% | |
| API | Product Name 产品名称 | CAS No. | Structure 结构式 | Patent 专利号 |
| Rosuvastatin 瑞舒伐他汀钙 |
Rosuvastatin methyl ester | 147118-40-9 |  |
ZL200910053047.3 ZL201511022824.X ZL201511022872.9 ZL201511023253.1 ZL201510940531.3 |
| Rosuvastatin tert-butyl ester | 355806-00-7 |  |
||
| Tert-butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetate | 289042-12-2 |  |
||
| Atorvastatin 阿托伐他汀钙 |
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β- diphenylbenzene butaneamide | 125971-96-2 |  |
ZL200810202127.6 |
| Diprotected Atorvastatin (L1) | 125971-95-1 |  |
||
| Perindopril 培哚普利 |
N-[(S)-1-Carbethoxybutyl]-(S)-alanine | 82834-12-6 |  |
ZL201210555176.4 ZL200910266685.3 |
| (S)-Indoline-2-carboxylic acid | 79815-20-6 |  |
||
| (2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid | 80875-98-5 |  |
||
| (2S,3aS,7aS)-Benzyl octahydro-1H-indole-2-carboxylate 4-methylbenzenesulfonate | 94062-52-9 |  |
||
| Ivabradine 伊伐布雷定 |
3-(3-Iodopropyl)-7,8-dimethoxy-1,3-dihydro-2H-3-benzapine-2-one | 148870-57-9 |  |
ZL201010207206.3 |
| [N-[[3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl] carbonyl]-N-methylamine] | 866783-13-3 |  |
||
| 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one | 73942-87-7 |  |
||
| Candesartan 坎地沙坦 |
Trityl candesartan | 139481-72-4 |  |
ZL201010229921.7 ZL201510671739.X |
| Ezetimibe 依替米贝 |
(4s)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone | 189028-93-1 |  |
ZL201511030652.0 |
| (S)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one | 189028-95-3 |  |
||
| Methyl 3-[(2S,3R)-2-[4-(benzyloxy)phenyl]-1-(4-fluorophenyl)-4-oxoazetidin-3-yl]propanoate | 204589-80-0 |  |
||
| 1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(phenylmethoxy)phenyl]-(3R,4S)-2-azetidinone | 190595-65-4 |  |
||
| Galantamine 加兰他敏 |
(+/-) Nawedine | 1668-86-6 |  |
|
| 4a,5,9,10,11,12-Hexahydro-1-bromo-3-methoxy-11-formyl- 6H-Benzofuro[3a,3,2-ef][2] benzazepine-6-one | 122584-14-9 |  |
||
| Valsartan 缬沙坦 |
Methyl N-[(2’-Cyanobiphenyl-4-yl)methyl]-L-valinate hydrochloride | 482577-59-3 |  |
ZL201010173862.6 ZL201510945518.7 |
| Clopidogrel 氯吡格雷 |
(S)-Methyl (2-chlorophenyl)[(2-(2-thienyl)amino] acetate hydrochloride | 141109-19-5 |  |
ZL201310462551.5 |
| Pregabalin 普瑞巴林 |
(R)-(-)-3-(Carbamoylmethyl-5-methylmexanoic acid | 181289-33-8 |  |
ZL201410137925.0 ZL201410675675.6 |
| 3-Carbamoymethyl-5-methylhexanoic acid | 181289-15-6 |  |
||
| Venlafaxine 文拉法辛 |
1-[2-Amino-1-(4-methoxyphenyl)-ethyl]-cyclohexanol | 130198-05-9 |  |
ZL200910100326.0 |
| Duloxetine 度洛西汀 |
(S)-3-(Methylamino)-1-(2-thienyl)-1-propanol | 116539-55-0 |  |
ZL201410436429.5 |
| S-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine | 132335-44-5 |  |
||
| S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate | 132335-47-8 |  |
||
| Levocetirizine 左西替利嗪 |
(-)-1-[(4-Chlorophenyl) phenylmethyl]piperazine | 300543-56-0 |  |
|
| Donepezil 多奈哌齐 |
5,6-Dimethoxy-2-(4-piperidinylmet hyl)-1-indanone | 120014-30-4 |  |
|
| Dabigatran 达比加群 |
Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate | 429659-01-8 |  |
ZL201510411877.4 |
| 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester | 212322-56-0 |  |
||
| 2-(4-Cyanophenylamino)acetic acid | 42288-26-6 |  |
||
| Ethyl 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino] propionate | 211915-84-3 |  |
||
| N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | 429658-95-7 |  |
||
| Ropinirole 罗匹尼罗 |
4-(2-Hydroxyethyl)-2H-indolin-2-one |
139122-19-3 |
 |
|
| Vildagliptin 维格列汀 |
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide | 214398-99-9 |  |
ZL201410112710.3 |
| (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 |  |
||
| Dapagliflozin 达格列净 |
5-Bromo-2-chloro-4’-ethoxydiphenylmethane | 461432-23-5 |  |
ZL201510404207.X |
| Lesinurad 利拉利德 |
1-Cyclopropyl-4-isothiocyanatonaphthalene | 878671-95-5 |  |
|
| 3H-1,2,4-Triazole-3-thione, 5-amino-4-(4-cyclopropyl-1-naphthalenyl)-2,4-dihydro | 878671-96-6 |  |
||
| Isopropyl 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | NA |  |
||
| Sitagliptin 西他列汀 |
5-[1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione | 767340-03-4 |  |
|
| (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine | 486460-32-6 |  |
||
| (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one | 486460-32-6 |  |
||
| Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | 486460-00-8 |  |
||
| Safinamide 沙芬酰胺 |
4-((3-Fluorobenzyl)oxy)benzaldehyde | 66742-57-2 |  |
ZL201510952335.8 |
| (S)-2((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide | 133865-89-1 |  |
走进美诺华
产品与服务
新闻中心
社会责任
投资者关系
